Sprachen · English. Muttersprache oder zweisprachig · French. Fließend · Spanish. Gute Kenntnisse · German. Grundkenntnisse.

Aram Mangasarian was appointed CEO of TME Pharma (formerly NOXXON Pharma) in July 2015. He has transformed the company into a lean, publicly quoted company.

Aram Mangasarian was appointed CEO of TME Pharma (formerly NOXXON Pharma) in July 2015. He has transformed the company into a lean, publicly quoted company focused on targeting the tumor microenvironment to improve the treatment of solid tumors.

Aram Mangasarian currently works at Noxxon Pharma. Aram does research in Oncology, Infectious Diseases and Clinical Pharmacology.

2023. gada 13. nov. · Aram Mangasarian is the CEO of NOXXON Pharma – a lean, publicly quoted company focused on targeting the tumor microenvironment to improve the treatment of ...

Aram Mangasarian is Chief Executive Officer at Noxxon Pharma NV. See Aram Mangasarian's compensation, career history, education, & memberships.

CEO, @AramMangasarian & Dr. Frank Giordano. To participate, send an email to [email protected] #NOXXON #NOXA12

Aram Mangasarian. Aram Mangasarian. Company: TME Pharma. Job title: CEO. Seminars: TME Pharma Case Study – Combination 2:00 pm. Overview of the rationale behind ...

2024. gada 1. sept. · Dr. Aram Mangasarian is the CEO & Member of Management Board at NOXXON Pharma NV.

Aram Mangasarian was appointed CEO of NOXXON in July 2015 after having served as Chief Business Officer of the company since May 2010.